#7,643 by institutional money · ETF
Virtus Biotech Clinical Trials ETF (BBC)
Institutional ownership from Q3 2026 Form 13F filings
$39.77
0.00% today
Market closed. Prices as of Nov 20, 7:41 AM ET
- 13F holders
- 17 (−3)
- Held by 13F filers, live
- $13.1M
- Shares held
- 329,523
- Share of stock outstanding
- n/a
- Net buying in Q3 2026
- −$1.9M
- New positions / sold out
- 3 / 6
Largest holders
17 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Kera Capital Partners, Inc. | 115,982 | $4.6M | 0.41% | Added +15% |
| Wealth Enhancement Advisory Services, LLC | 75,708 | $3.0M | <0.1% | Added +10% |
| Citadel Advisors LLC Ken Griffin | 37,268 | $1.5M | <0.1% | Reduced −13% |
| Quantinno Capital Management LP | 26,926 | $1.1M | <0.1% | Added +17% |
| Susquehanna International Group, LLP | 23,649 | $941K | <0.1% | Reduced −39% |
| Militia Capital Management LLC | 23,356 | $929K | 0.14% | Reduced −49% |
| LPL Financial LLC | 10,174 | $405K | <0.1% | Reduced −17% |
| Morgan Stanley | 8,404 | $334K | <0.1% | Reduced −44% |
| Osaic Holdings, Inc. | 5,236 | $208K | <0.1% | Added +17% |
| UBS Group AG | 2,079 | $83K | <0.1% | Reduced −1% |
| Dynamic Wealth Strategies, LLC | 500 | $20K | <0.1% | Reduced −46% |
| Federation des caisses Desjardins du Quebec | 110 | $4K | <0.1% | Unchanged |
| Royal Bank Of Canada | 65 | $3K | <0.1% | New |
| Compass Financial Management LLC | 49 | $2K | <0.1% | Reduced −91% |
| Allworth Financial LP | 10 | $398 | <0.1% | Unchanged |
| Blue Trust, Inc. | 6 | $239 | <0.1% | New |
| Citigroup Inc | 1 | $40 | <0.1% | New |